ArticleFrontiers in medicine2022

Real clinical experience after one year of treatment with tolvaptan in patients with autosomal dominant polycystic kidney disease.

Javier Naranjo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.